Partner David Simon was quoted in a Bloomberg Quint article, “How U.S. Companies Are Navigating The FCPA Risk In India,” about the perils of doing business in India.
Under the Dodd Frank Act, Simon said, a whistle-blower who comes to the Securities Exchange Commission with actionable information that may result in an enforcement action under the Foreign Corrupt Practices Act is entitled to monetary awards. “I’m surprised by how well-known this fact is to Indian employees of U.S. companies,” he said.
Simon also said he doesn’t believe it’s impossible to do business in India without paying bribes. “It requires preparation, patience and resources, but it can be done,” he said.
Under the Dodd Frank Act, Simon said, a whistle-blower who comes to the Securities Exchange Commission with actionable information that may result in an enforcement action under the Foreign Corrupt Practices Act is entitled to monetary awards. “I’m surprised by how well-known this fact is to Indian employees of U.S. companies,” he said.
Simon also said he doesn’t believe it’s impossible to do business in India without paying bribes. “It requires preparation, patience and resources, but it can be done,” he said.
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."